Mark Moasser
Professor In Residence · University of California (San Francisco) School of Medicine
Credentials: · · ·
History
Research
Review · Oncogene · 2007 · Sole author · 939 citations
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3
Nature · 2007 · Last of 7 authors · 805 citations
The epidermal growth factor receptor family: biology driving targeted therapeutics
Review · Cellular and Molecular Life Sciences · 2008 · 561 citations
- CH
12 papers
- GD
10 papers
10 papers
- LN
10 papers
- AS
9 papers
9 papers · 2 as a fellow
9 papers
8 papers
Grants
- 2007–2019
Understanding Resistance in the HER2-HER3 Tumor Drive
National Cancer Institute · R01
Contact PI · $3M · University of California, San Francisco
- 2005–2011
Adhesion Signaling by a Novel Mitotic Substrate of Src
National Cancer Institute · R01
Contact PI · $1.3M · University of California, San Francisco
- 2007–2009
Pilot Studies to Develop Probes for in vivo Imaging of P13K/Akt Pathway Activity
National Cancer Institute · R21
Contact PI · $338.9K · University of California, San Francisco
Clinical trials
- 2007–2013
Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2
Study chair · Completed · Phase 1
University of California, San Francisco
- 2006–2013
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors
Study chair · Completed · Phase 1
University of California, San Francisco